Cathelicidins as immunomodulators of host defence against infectious diseases

Status	Finished
Effective start/end date	1/04/11 → 31/03/17

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe Respiratory Syncytial Virus infection
Sintoris, S., Binkowska, J., Gillan, J., Zuurbier, R. P., Twynam-Perkins, J., Kristensen, M., Melrose, L., Lusarreta Parga, P., Ruiz-Rodriguez, A., Chu, M. L., Van Boeckel, S., Wildenbeest, J. G., Bowdish, D. M. E., Currie, A. J., Thwaites, R. S., Schwarze, J., van Houten, M. A., Boardman, J. P., Cunningham, S. & Bogaert, D. & 1 others, Davidson, D., 17 Jun 2024, In: Scientific Reports. 14, 1, 13928.
Research output: Contribution to journal › Article › peer-review

Open Access
A mechanistic evaluation of human beta defensin 2 mediated protection of human skin barrier in vitro
Shelley, J. R., Mchugh, B. J., Wills, J., Dorin, J. R., Weller, R., Clarke, D. J. & Davidson, D. J., 8 Feb 2023, In: Scientific Reports. 13, 1, 2271.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Dysregulation of Prostaglandins, Leukotrienes and Lipoxin A4 in Bronchiectasis
Bedi, P., Zeigler, K., Whitfield, P. D., Davidson, D. J., Rossi, A. G. & Hill, A., 17 Nov 2021, (E-pub ahead of print) In: Thorax.
Research output: Contribution to journal › Article › peer-review

Open Access
File

SSERC Higher Human Biology CPD
Davidson, D. J. (Presenter)
7 Mar 2017
Activity: Participating in or organising an event types › Public Engagement – Schools engagement

Project Details